CME Group Inc. (NASDAQ:CME) Shares Acquired by Comprehensive Financial Consultants Institutional Inc.

Comprehensive Financial Consultants Institutional Inc. increased its position in shares of CME Group Inc. (NASDAQ:CME) by 3.1% during the 3rd quarter, Holdings Channel.com reports. The fund owned 18,288 shares of the financial services provider’s stock after acquiring an additional 547 shares during the period. CME Group accounts for about 1.5% of Comprehensive Financial Consultants Institutional Inc.’s holdings, making the stock its 18th largest position. Comprehensive Financial Consultants Institutional Inc.’s holdings in CME Group were worth $4,035,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CME. Y.D. More Investments Ltd acquired a new position in shares of CME Group in the second quarter worth $36,000. McClarren Financial Advisors Inc. grew its stake in CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares in the last quarter. Asset Dedication LLC grew its stake in CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 170 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. increased its holdings in CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after purchasing an additional 74 shares during the period. Finally, Bank & Trust Co acquired a new stake in CME Group in the 2nd quarter valued at about $76,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Stock Up 0.4 %

CME opened at $222.04 on Friday. The company has a market cap of $79.96 billion, a price-to-earnings ratio of 23.35, a PEG ratio of 5.61 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a one year low of $190.70 and a one year high of $230.36. The business’s fifty day moving average is $221.36 and its two-hundred day moving average is $209.75.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business’s revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the business earned $2.25 earnings per share. Analysts anticipate that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.07%. CME Group’s payout ratio is 48.37%.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on CME shares. Redburn Atlantic lowered CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a research report on Tuesday, October 8th. The Goldman Sachs Group upped their price objective on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research note on Thursday, October 3rd. TD Cowen started coverage on CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price for the company. Barclays lifted their target price on shares of CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a report on Thursday, October 24th. Finally, Piper Sandler raised their price objective on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research report on Monday, October 28th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $222.73.

Insider Buying and Selling at CME Group

In related news, insider Timothy Francis Mccourt sold 1,374 shares of the firm’s stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the sale, the insider now directly owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of the business’s stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock valued at $3,441,063 over the last three months. 0.30% of the stock is owned by company insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.